EMA Recommends First Long-Acting Injectable HIV Treatment

The first long-acting injectable treatments for HIV were recommended for marketing approval on October 16 by the European Medicines Agency (EMA). A combination injection of two new antiretroviral (ARV) medicines, rilpivirine (Rekambys) and cabotegravir…

Continue Reading EMA Recommends First Long-Acting Injectable HIV Treatment

FDA Orders Stronger Warnings on Benzodiazepines

The US Food and Drug Administration (FDA) wants updated boxed warnings on benzodiazepines to reflect the "serious" risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions associated with these medications.…

Continue Reading FDA Orders Stronger Warnings on Benzodiazepines